In the closing of the recent trading day, CVS Health (CVS) stood at $65.75, denoting a +1.4% change from the preceding trading day.

We gleaned this information from our observations today when Benzinga's options scanner highlighted 13 extraordinary options ...

CVS higher-ups became suspicious when they took inventory and realized that they were missing hundreds of individual ...

The mysterious death of actor Gene Hackman and his wife rattled and baffled the Santa Fe community. New details emerge about the couple's final hours.

Shares of CVS Health Co. (NYSE:CVS – Get Free Report) have been given an average rating of “Moderate Buy” by the twenty-one ratings firms that are covering the stock, Marketbeat reports. Three ...

The furious parent complained on X that they had been waiting for several minutes before being told they could not complete ...

Several major skin care brands like L’Oréal Paris and Proactiv issued a recall of their products due to elevated levels of ...

A prescription fraud scheme spanning D.C., Maryland and Virginia is under investigation by Montgomery County detectives, ...

Celltrion and Formycon with Fresenius Kabi launched their respective ustekinumab biosimilars (Steqeyma and Otulfi), joining 4 ...

Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of ...

The Menopause Friendly Accreditation from MiDOViA, a program that launched in the U.K. to improve workplaces for women in ...

Pure Source, a U.S.-owned and operated contract manufacturer and global supplier of personal care and OTC products, proudly ...